Who
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $197K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Nov 2025
- Last trade
- 21 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $11K2,872 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $4,2811,110 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $11K2,872 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $4,2851,110 at $3.86 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $17K2,683 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $6,4931,036 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $17K2,683 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $6,4961,036 at $6.27 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $26K4,387 at $5.87 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $3,440602 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $112 at $5.70 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $26K4,387 at $5.87 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $3,437602 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $112 at $5.70 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Code A | —46,200 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ARDX Ardelyxoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,360 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ARDX Ardelyxoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,360 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Code A | —46,200 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $61K11,086 at $5.54 | filing |
News
Pomerantz LLP Issues Important Reminder to Investors in Ardelyx, Inc. ...ARDX · pr-inside.com · 25 Oct 2026Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate BindersARDX · manilatimes.net · 23 Oct 2026November 16, 2026 Deadline: Join Class Action Lawsuit Against Ardelyx, ...ARDX · pr-inside.com · 20 Oct 2026
0 headlines in the last 90 days name Joseph James Reilly; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.